Advanced search
Publication Cover
International Journal of Neuroscience Volume 129, 2019 - Issue 6
Submit an article Journal homepage
177
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

A case of fatal invasive aspergillosis in a patient with neurosarcoidosis treated with infliximab

Carson Van SanfordDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, USA; Correspondence[email protected]
View further author information
,
Ahmed Z. ObeidatDepartment of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA; View further author information
,
Matthew HagenDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USAView further author information
&
Aram ZabetiDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, USA; View further author information
Pages 619-622 | Received 07 Aug 2018, Accepted 29 Oct 2018, Published online: 28 Nov 2018

References

  • Terushkin V, Stern BJ, Judson MA, et al. Neurosarcoidosis: presentations and management. Neurologist 2010;16:2–15.
  • Gelfand JM, Bradshaw MJ, Stern B, et al. Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series. Neurology 2017;89:2092–2100.
  • Gregg KS, Kauffman CA. Invasive aspergillosis: epidemiology, clinical aspects, and treatment. Semin Respir Crit Care Med. 2015;36:662–672.
  • Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358–366.
  • Orenstein R, Matteson E. Opportunistic infections associated with TNF-a treatment. Future Rheumatol. 2007;2:567–576.
  • Bourne EL, Dimou J. Invasive central nervous system aspergillosis in a patient with Crohn’s disease after treatment with infliximab and corticosteroids. J Clin Neurosci. 2016;30:163–164.
  • Uzunhan Y, Nunes H, Jeny F, et al. Chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J. 2017;49:1602396.
  • Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, et al. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132 patients. Seminars Arthritis Rheumatism 2017;47:288–294.
  • Cohen Aubart F, Bouvry D, Galanaud D, et al. Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol. 2017;264:891–897.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.